ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
2 announcements with these filters
Eris Lifesciences filed its quarterly shareholding pattern for the period ending June 30, 2026. No major promoter changes or material financial events reported.
Eris Lifesciences filed its FY2026 Secretarial Compliance Report, noting a Rs. 0.13 Crore fine for delayed director appointment. The company has since achieved full compliance.